SLC2A3 and cancer: Comparative analysis of tumor and adjacent normal tissues revealed that SLC2A3 expression was significantly upregulated in eight cancer types, including STES, KIPAN, STAD, HNSC, KIRC, PAAD, TGCT, and CHOL.